Chiesi USA, Inc. · 16 hours ago
Intern, Medical Affairs, Global Rare Diseases - Summer 2026
Chiesi USA, Inc. is an international research-focused biopharmaceutical group dedicated to promoting a healthier world. The Global Rare Diseases Medical Affairs Intern will support strategic and operational initiatives within the Medical Affairs team, gaining hands-on experience in medical strategy, evidence generation, and stakeholder engagement across the rare disease portfolio.
BiotechnologyMedicalPharmaceutical
Responsibilities
Assist in the development of medical strategies for product launches and portfolio initiatives
Support scientific communication activities, including educational materials and internal/external presentations
Contribute to the planning and execution of advisory boards and key internal meetings
Collaborate on evidence generation projects, including literature reviews and data synthesis
Prepare briefing documents and slide decks for global medical and cross-functional teams
Participate in cross-functional discussions to understand integration of medical insights into broader business strategies
Qualification
Required
Current enrollment in an undergraduate or graduate program (PharmD, MD, PhD, MPH, or related life sciences field) with an expected graduation date of Fall 2026 or later
Strong interest in rare diseases and medical affairs
Exceptional written and verbal communication skills, including the ability to present complex information clearly and concisely
Ability to manage multiple tasks in a fast-paced environment
Proficiency in Microsoft Office Suite
Comfort working in a multicultural, cross-functional setting with sensitivity to diverse perspectives
Preferred
Familiarity with scientific literature databases preferred
Company
Chiesi USA, Inc.
Chiesi USA is a pharmaceuticals company specializing in pharmaceutical research & development services.
Funding
Current Stage
Growth StageTotal Funding
$0MKey Investors
North Carolina Biotechnology Center
2020-08-04Grant· $0M
Leadership Team
Recent News
Clinical Trials Arena
2024-05-24
Company data provided by crunchbase